Fluorescent in situ hybridization detection of HER-2/neu gene amplification in rhabdomyosarcoma

Hon Fong L Mark, Stephen Brown, Ci Lin Sun, Mangala Samy, Alaa M Afify

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Embryonal rhabdomyosarcoma is the most common malignant soft-tissue tumor in childhood, comprising 45-50% of childhood sarcomas. Cytogenetic studies of this tumor are rare. In view of the paucity of cytogenetic data on this cancer and based on the finding of HER-2/neu gene amplification in a number of cancers that was detected mostly using the traditional technique of immunohistochemistry, we decided to conduct a pilot study to investigate whether HER-2/neu gene amplification in this tumor can be detected using the newer technique of fluorescent in situ hybridization (FISH). Archival tissues of rhabdomyosarcoma were retrieved and FISH using an HER-2/neu probe was undertaken on formalin-fixed paraffin-embedded tissue sections using a protocol optimized for our laboratory at Rhode Island Hospital. Out of 9 cases of rhabdomyosarcoma studied to date, 1 case clearly showed HER-2/neu gene amplification. Thus, FISH is a sensitive technique suitable for the detection of oncogene amplification and the delineation of tumor heterogeneity in this tumor. Future experiments utilizing additional specimens from our centers as well as from other laboratories will be needed to extend the finding in the present pilot study.

Original languageEnglish (US)
Pages (from-to)59-63
Number of pages5
JournalPathobiology
Volume66
Issue number2
DOIs
StatePublished - 1998
Externally publishedYes

Fingerprint

erbB-2 Genes
Rhabdomyosarcoma
Gene Amplification
Fluorescence In Situ Hybridization
Tumors
Neoplasms
Tissue
Cytogenetics
Embryonal Rhabdomyosarcoma
Paraffin
Formaldehyde
Amplification
Oncogenes
Sarcoma
Immunohistochemistry
Experiments

Keywords

  • Fluorescent in situ hybridization
  • HER-2/neu oncogene amplification
  • Rhabdomyosarcoma

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Clinical Biochemistry
  • Immunology and Allergy
  • Cell Biology

Cite this

Fluorescent in situ hybridization detection of HER-2/neu gene amplification in rhabdomyosarcoma. / Mark, Hon Fong L; Brown, Stephen; Sun, Ci Lin; Samy, Mangala; Afify, Alaa M.

In: Pathobiology, Vol. 66, No. 2, 1998, p. 59-63.

Research output: Contribution to journalArticle

Mark, Hon Fong L ; Brown, Stephen ; Sun, Ci Lin ; Samy, Mangala ; Afify, Alaa M. / Fluorescent in situ hybridization detection of HER-2/neu gene amplification in rhabdomyosarcoma. In: Pathobiology. 1998 ; Vol. 66, No. 2. pp. 59-63.
@article{aa31077a4d8c449eb6b601de094e4f59,
title = "Fluorescent in situ hybridization detection of HER-2/neu gene amplification in rhabdomyosarcoma",
abstract = "Embryonal rhabdomyosarcoma is the most common malignant soft-tissue tumor in childhood, comprising 45-50{\%} of childhood sarcomas. Cytogenetic studies of this tumor are rare. In view of the paucity of cytogenetic data on this cancer and based on the finding of HER-2/neu gene amplification in a number of cancers that was detected mostly using the traditional technique of immunohistochemistry, we decided to conduct a pilot study to investigate whether HER-2/neu gene amplification in this tumor can be detected using the newer technique of fluorescent in situ hybridization (FISH). Archival tissues of rhabdomyosarcoma were retrieved and FISH using an HER-2/neu probe was undertaken on formalin-fixed paraffin-embedded tissue sections using a protocol optimized for our laboratory at Rhode Island Hospital. Out of 9 cases of rhabdomyosarcoma studied to date, 1 case clearly showed HER-2/neu gene amplification. Thus, FISH is a sensitive technique suitable for the detection of oncogene amplification and the delineation of tumor heterogeneity in this tumor. Future experiments utilizing additional specimens from our centers as well as from other laboratories will be needed to extend the finding in the present pilot study.",
keywords = "Fluorescent in situ hybridization, HER-2/neu oncogene amplification, Rhabdomyosarcoma",
author = "Mark, {Hon Fong L} and Stephen Brown and Sun, {Ci Lin} and Mangala Samy and Afify, {Alaa M}",
year = "1998",
doi = "10.1159/000027997",
language = "English (US)",
volume = "66",
pages = "59--63",
journal = "Pathobiology",
issn = "1015-2008",
publisher = "S. Karger AG",
number = "2",

}

TY - JOUR

T1 - Fluorescent in situ hybridization detection of HER-2/neu gene amplification in rhabdomyosarcoma

AU - Mark, Hon Fong L

AU - Brown, Stephen

AU - Sun, Ci Lin

AU - Samy, Mangala

AU - Afify, Alaa M

PY - 1998

Y1 - 1998

N2 - Embryonal rhabdomyosarcoma is the most common malignant soft-tissue tumor in childhood, comprising 45-50% of childhood sarcomas. Cytogenetic studies of this tumor are rare. In view of the paucity of cytogenetic data on this cancer and based on the finding of HER-2/neu gene amplification in a number of cancers that was detected mostly using the traditional technique of immunohistochemistry, we decided to conduct a pilot study to investigate whether HER-2/neu gene amplification in this tumor can be detected using the newer technique of fluorescent in situ hybridization (FISH). Archival tissues of rhabdomyosarcoma were retrieved and FISH using an HER-2/neu probe was undertaken on formalin-fixed paraffin-embedded tissue sections using a protocol optimized for our laboratory at Rhode Island Hospital. Out of 9 cases of rhabdomyosarcoma studied to date, 1 case clearly showed HER-2/neu gene amplification. Thus, FISH is a sensitive technique suitable for the detection of oncogene amplification and the delineation of tumor heterogeneity in this tumor. Future experiments utilizing additional specimens from our centers as well as from other laboratories will be needed to extend the finding in the present pilot study.

AB - Embryonal rhabdomyosarcoma is the most common malignant soft-tissue tumor in childhood, comprising 45-50% of childhood sarcomas. Cytogenetic studies of this tumor are rare. In view of the paucity of cytogenetic data on this cancer and based on the finding of HER-2/neu gene amplification in a number of cancers that was detected mostly using the traditional technique of immunohistochemistry, we decided to conduct a pilot study to investigate whether HER-2/neu gene amplification in this tumor can be detected using the newer technique of fluorescent in situ hybridization (FISH). Archival tissues of rhabdomyosarcoma were retrieved and FISH using an HER-2/neu probe was undertaken on formalin-fixed paraffin-embedded tissue sections using a protocol optimized for our laboratory at Rhode Island Hospital. Out of 9 cases of rhabdomyosarcoma studied to date, 1 case clearly showed HER-2/neu gene amplification. Thus, FISH is a sensitive technique suitable for the detection of oncogene amplification and the delineation of tumor heterogeneity in this tumor. Future experiments utilizing additional specimens from our centers as well as from other laboratories will be needed to extend the finding in the present pilot study.

KW - Fluorescent in situ hybridization

KW - HER-2/neu oncogene amplification

KW - Rhabdomyosarcoma

UR - http://www.scopus.com/inward/record.url?scp=0031960660&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031960660&partnerID=8YFLogxK

U2 - 10.1159/000027997

DO - 10.1159/000027997

M3 - Article

VL - 66

SP - 59

EP - 63

JO - Pathobiology

JF - Pathobiology

SN - 1015-2008

IS - 2

ER -